
    
      Prospective, uncontrolled, multicenter, Italian, investigator-initiated, phase II clinical
      study to explore the activity of trabectedin in a population of patients aged â‰¥16 years with
      progressive, advanced (locally advanced or metastatic), HEY1-NCOA2 positive MCS) ,
      pre-treated with anthracycline-based chemotherapy.
    
  